Amber Robins, MD, has written The Write Prescription with you in mind. Listen to this interview to find out more about how you can use this book as a foundation for your personal legacy.
Amber Robins, MD, is a Family Medicine Resident and graduate of the University of Rochester School of Medicine and Dentistry. Dr. Robins is originally from Louisiana where she enjoyed southern hospitality. She attended Xavier University of Louisiana and graduated Magna Cum Laude as a Biology major and Chemistry minor. During her senior year of ungergrad, she was elected Miss Xavier University of Louisiana 2009-2010.
Amber has been active in various research studies that include gynecologic cancers, adolescent mothers, and minorities in medicine. At the University of Rochester School of Medicine and Dentistry, she was awarded as a member of the Medical Education Pathway. Within this pathway, she began to develop her love of teaching medical students through lectures and small group sessions. In addition to her work in medical school, Dr. Robins founded a community step team and traveled to Rabat, Morocco, as an English teacher over the summer between her first and second year of medical school.She is also a writer for The Journal for Minority Medical Students in her own column entitled “Diary of a Medical Student”.
Throughout her journey, Dr. Robins’s goal is to continue motivating others to achieve their own personal successes. She is constantly reminded that dreams do come true with faith in God and hard work. Now that she lives in Upstate NY, she desires to touch the world through her experiences and stories of life as a resident and advocate for mankind.
To Learn More
Recent episodes from Tamara "Tami" Patzer (see all)
- Leading Expert Dr. Elra Morgan Brings Revolutionary Laser Therapy to St. Clair County for Pain Management - March 16, 2023
- CONNOR HIEBEL: Teen Awarded $10,000 Grant for FedEx Entrepreneur Fund For Empowering People - November 21, 2022
- Face the Music: Saving Lives One Note at a Time with Drs. Robert Hanopole, Michael Rubenstein and Founder Paul Pellinger - November 3, 2022